Previous studies demonstrated that pharmacological inhibition of AQP1 water and ion channels was an effective tool for limiting colon cancer cell motility measured in both wound closure assays and transwell invasion tests [79]. This evidence concerns the gene AQP1 and malignant colon neoplasm.